Department of Bioengineering and Therapeutic Sciences

Could this Molecule be ‘Checkmate’ for Coronaviruses like SARS-CoV-2?

Thu Apr 24, 2025
Craik

Charles Craik, PhD

Powerful drug candidates perform better than Paxlovid against SARS-CoV-2 and could head off future coronavirus pandemics. The research, from a team at UCSF and Gladstone Institutes that includes School of Pharmacy researchers, has stalled since the grant was cut.

Bridging borders in science: Q&A with Einstein Visiting Fellow Nevan Krogan, PhD

Wed Apr 23, 2025
The Department of Bioengineering and Therapeutic Sciences professor will lead a new global research initiative with Freie Universität Berlin, establishing a Berlin-based lab to advancing cross-border collaboration and innovation in structural biology, infectious disease and therapeutic discovery.

Full Circle Symposium Brings Together Native and Indigenous Scientists

Fri Apr 11, 2025
Coyote-Maestas

Department of Bioengineering and Therapeutic Sciences Assistant Professor Willow Coyote-Maestas, PhD, MS

Led by Department of Bioengineering and Therapeutic Sciences Assistant Professor Willow Coyote-Maestas, PhD, MS, and presented by the school’s Quantitative Biosciences Institute (QBI), the symposium — which is open to all — aims to build a thriving community for Native and Indigenous scientists in...

Koda-Kimble Seed Award Fuels 11 Innovative Projects

Mon Mar 31, 2025
Eleven innovative projects with the potential to further the mission of the UCSF School of Pharmacy in new ways will garner a financial boost from the 2025 Mary Anne Koda-Kimble Seed Award for Innovation.

Kortemme awarded International Feodor Lynen Medal from the German Society for Biochemistry and Molecular Biology

Thu Mar 20, 2025
Kortemme

Tanja Kortemme, PhD

The school’s vice dean of research received the award at an annual event that fosters scientific exchange among experts in biochemistry and molecular biology, where she delivered a lecture that delved into her work on the creation of novel proteins and their applications in engineering molecular...

Decoding COVID-19: QBI Researchers Pave the Way for New Drug Discoveries to Combat Virus

Tue Mar 11, 2025
Krogan (left) in his lab with Xu (right)
Susan Merrell

Nevan Krogan, PhD, left, director of the Quantitative Biosciences Institute and founder of the UCSF Coronavirus Research Group, and Jiewei Xu, specialist in the department of Cellular & Molecular Pharmacology, worked around the clock mapping human proteins with the goal of finding a drugs to prevent COVID from replicating.

The QBI Coronavirus Research Group (QCRG) fast-tracked antiviral drug discovery by partnering with scientists around the globe and around the clock, deepening understanding of how viruses attack cells and shaping the future of pandemic preparedness.

Lessons Learned: Five Years of COVID-19 Research and Response at UCSF

Tue Mar 11, 2025
SARS-CoV-2
National Institutes of Health
UCSF School of Pharmacy experts share their perspectives on the lessons learned from the pandemic and the evolving role of pharmacy in strengthening public health, advancing scientific discovery and preparing for future global challenges.

How AI Drug Manufacturing Is Changing the Game

Thu Mar 6, 2025

UCSF School of Pharmacy Leads in NIH Funding for 45th Consecutive Year

Wed Feb 26, 2025
Krogan and lab member
Noah Berger

Nevan Krogan, PhD, speaks with a research associate in his lab.

The UCSF School of Pharmacy continues to lead the country in competitive federal research funding among pharmacy schools, capturing $45.8 million in 2024 to fuel life-changing drug discoveries, bioengineering, pharmacokinetics and more.

UCSF Scientists Discover How Hungry Fat Cells Could Someday Starve Cancer to Death

Tue Feb 4, 2025
Ahituv

Nadav Ahituv, PhD

Department of Bioengineering and Therapeutic Sciences professor Nadav Ahituv is part of a team of researchers using the gene editing technology CRISPR to deprive tumors of nutrition.

Pages